Bohuslav M.
- Country
- Czechia
- Department
- Onkologická klinika
Research Overview
- Evaluation of Safety and Efficacy of Elacestrant in Combination Therapies for Patients with Metastatic Breast Cancer: A Phase 1b/2 Open-Label Umbrella Study
- A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS<50% Non-squamous Non-small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-Lung07)
- Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 722 of 1087 partner sites.
Specializations
Breast Cancer Research
Focused on investigating therapeutic approaches for hormone receptor-positive HER2-negative breast cancer and HER2-positive early breast cancer, including novel combination treatments.
- Advanced metastatic breast cancer treatment
- Endocrine therapy combinations
- HER2-targeted therapies
Gastrointestinal Oncology
Specializes in treating various gastrointestinal cancers including colorectal cancer, pancreatic adenocarcinoma, and gastrointestinal stromal tumors.
- Metastatic colorectal cancer therapies
- Advanced pancreatic cancer treatment
- Microsatellite instability studies
Urological Cancers
Expertise in treating urothelial carcinoma, prostate cancer, and renal cell carcinoma with innovative therapeutic approaches.
- Advanced prostate cancer treatments
- Metastatic urothelial cancer therapy
- Renal cell carcinoma interventions
Skin Cancer and Melanoma
Specializes in treating advanced melanoma with focus on immunotherapy combinations and novel therapeutic approaches.
- Unresectable melanoma treatment
- Immunotherapy combinations
- Metastatic disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.